OHIO STATE UNIVERSITY AND BIOSORTIA PHARMACEUTICALS TO JOIN FORCES TO DISCOVER ANTI-CANCER COMPOUNDS
Biosortia Pharmaceuticals Creating Drug Discovery Opportunity with Previously Unstudied Microorganisms. Dublin, Ohio (February 26, 2013) – The Ohio State University has signed an agreement with Biosortia Pharmaceuticals of Dublin, Ohio to
President & CEO Kurt Dieck And Founder Ross Youngs Will Present The Business And Science Of Biosortia Pharmaceuticals’ Disruptive Drug Discovery Technologies At CMC Event.
Dublin, Ohio (February 25, 2013) – On March 6th the Columbus Metropolitan Club at the Athletic Club of Columbus will host a lunch meeting where Biosortia Pharmaceuticals’ President & CEO Kurt
BIOSORTIA PHARMACEUTICALS RECEIVES PROCLAMATION FROM CITY OF DUBLIN OHIO
Ross Youngs Founder of Biosortia Pharmaceuticals accepted a Proclamation as an Entrepreneurial representative that recognizes how vital entrepreneurship is to growth and prosperity from Timothy A. Lecklider, Mayor of Dublin
BIOSORTIA CHASING DRUG DISCOVERIES FROM ALGAE HARVEST
By Carrie Ghose, (February 1, 2013) – The same mystery toxins from blooms of algae that sicken swimmers and kill fish also might be the source of drugs to fight cancer
ALGAEVENTURE PHARMA SPINOFF HIRES CARDINAL HEALTH VETERAN AS CEO
Biosortia Pharmaceuticals, a Dublin-based subsidiary of Marysville-based Algaeventure Systems Inc. announced its CEO is Kurt Dieck Columbus, Ohio (January 28, 2013) – A startup prospecting mucky ponds for the pharmaceutical
INNOVATIVE DRUG DISCOVERY BUSINESS, BIOSORTIA PHARMACEUTICALS, LANDS TWO HEALTHCARE VETERANS
Biosortia Pharmaceuticals Hires Kurt Dieck as President and CEO to Accelerate Strategy to Develop and License New Highly Active Compounds from Unculturable Aquatic Microbial Consortia Dublin, Ohio (January 22, 2013) –
NOAA SIGNS CRADA WITH BIOSORTIA PHARMACEUTICALS
Algae Sampling Technology Partnership to Find, Exploit Novel Chemical Compounds Published (October 30, 2012) – A pharmaceutical research and development startup and NOAA signed an agreement designed with two goals in